Autoimmune Diseases  >>  Venclexta (venetoclax)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Venclexta (venetoclax) / Roche, AbbVie
NCT01686555: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Completed
1
97
US, Europe, RoW
ABT-199, Placebo
AbbVie (prior sponsor, Abbott)
Lupus Erythematosus
06/15
06/15

Download Options